Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Comparative Effectiveness of Sleep Apnea Screening Instruments During Inpatient Rehabilitation Following Moderate to Severe TBI.

Nakase-Richardson R, Schwartz DJ, Drasher-Phillips L, Ketchum JM, Calero K, Dahdah MN, Monden KR, Bell K, Magalang U, Hoffman J, Whyte J, Bogner J, Zeitzer JM.

Arch Phys Med Rehabil. 2019 Nov 6. pii: S0003-9993(19)31364-4. doi: 10.1016/j.apmr.2019.09.019. [Epub ahead of print]

PMID:
31705855
2.

Complex interactions between the microbiome and cancer immune therapy.

Schwartz DJ, Rebeck ON, Dantas G.

Crit Rev Clin Lab Sci. 2019 Dec;56(8):567-585. doi: 10.1080/10408363.2019.1660303. Epub 2019 Sep 17.

PMID:
31526274
3.

Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections.

Thänert R, Reske KA, Hink T, Wallace MA, Wang B, Schwartz DJ, Seiler S, Cass C, Burnham CA, Dubberke ER, Kwon JH, Dantas G.

MBio. 2019 Aug 27;10(4). pii: e01977-19. doi: 10.1128/mBio.01977-19.

4.

Functional improvement after severe brain injury with disorder of consciousness paralleling treatment for comorbid obstructive sleep apnoea: a case report.

Silva MA, Schwartz DJ, Nakase-Richardson R.

Int J Rehabil Res. 2019 Sep;42(3):285-288. doi: 10.1097/MRR.0000000000000364.

PMID:
31283551
5.

Ureaplasma urealyticum pyelonephritis presenting with progressive dysuria, renal failure, and neurologic symptoms in an immunocompromised patient.

Schwartz DJ, Elward A, Storch GA, Rosen DA.

Transpl Infect Dis. 2019 Apr;21(2):e13032. doi: 10.1111/tid.13032. Epub 2018 Dec 10.

6.

A Model of Δ9-Tetrahydrocannabinol Self-administration and Reinstatement That Alters Synaptic Plasticity in Nucleus Accumbens.

Spencer S, Neuhofer D, Chioma VC, Garcia-Keller C, Schwartz DJ, Allen N, Scofield MD, Ortiz-Ithier T, Kalivas PW.

Biol Psychiatry. 2018 Oct 15;84(8):601-610. doi: 10.1016/j.biopsych.2018.04.016. Epub 2018 May 3. Erratum in: Biol Psychiatry. 2019 May 15;85(10):881.

7.

Association Between Use of Acid-Suppressive Medications and Antibiotics During Infancy and Allergic Diseases in Early Childhood.

Mitre E, Susi A, Kropp LE, Schwartz DJ, Gorman GH, Nylund CM.

JAMA Pediatr. 2018 Jun 4;172(6):e180315. doi: 10.1001/jamapediatrics.2018.0315. Epub 2018 Jun 4.

8.

A mucosal imprint left by prior Escherichia coli bladder infection sensitizes to recurrent disease.

O'Brien VP, Hannan TJ, Yu L, Livny J, Roberson ED, Schwartz DJ, Souza S, Mendelsohn CL, Colonna M, Lewis AL, Hultgren SJ.

Nat Microbiol. 2016 Oct 31;2:16196. doi: 10.1038/nmicrobiol.2016.196.

9.

Implementation of Actigraphy in Acute Traumatic Brain Injury (TBI) Neurorehabilitation Admissions: A Veterans Administration TBI Model Systems Feasibility Study.

Towns SJ, Zeitzer J, Kamper J, Holcomb E, Silva MA, Schwartz DJ, Nakase-Richardson R.

PM R. 2016 Nov;8(11):1046-1054. doi: 10.1016/j.pmrj.2016.04.005. Epub 2016 May 10.

PMID:
27178377
10.

Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).

Sio TT, Atherton PJ, Birckhead BJ, Schwartz DJ, Sloan JA, Seisler DK, Martenson JA, Loprinzi CL, Griffin PC, Morton RF, Anders JC, Stoffel TJ, Haselow RE, Mowat RB, Wittich MA, Bearden JD 3rd, Miller RC.

Support Care Cancer. 2016 Sep;24(9):3847-55. doi: 10.1007/s00520-016-3213-3. Epub 2016 Apr 14.

11.

Concordance of Actigraphy With Polysomnography in Traumatic Brain Injury Neurorehabilitation Admissions.

Kamper JE, Garofano J, Schwartz DJ, Silva MA, Zeitzer J, Modarres M, Barnett SD, Nakase-Richardson R.

J Head Trauma Rehabil. 2016 Mar-Apr;31(2):117-25. doi: 10.1097/HTR.0000000000000215.

PMID:
26959665
12.

Incidence, Characterization, and Predictors of Sleep Apnea in Consecutive Brain Injury Rehabilitation Admissions.

Holcomb EM, Schwartz DJ, McCarthy M, Thomas B, Barnett SD, Nakase-Richardson R.

J Head Trauma Rehabil. 2016 Mar-Apr;31(2):82-100. doi: 10.1097/HTR.0000000000000230.

PMID:
26959663
13.

Addiction-like Synaptic Impairments in Diet-Induced Obesity.

Brown RM, Kupchik YM, Spencer S, Garcia-Keller C, Spanswick DC, Lawrence AJ, Simonds SE, Schwartz DJ, Jordan KA, Jhou TC, Kalivas PW.

Biol Psychiatry. 2017 May 1;81(9):797-806. doi: 10.1016/j.biopsych.2015.11.019. Epub 2015 Dec 2.

14.

Coding the direct/indirect pathways by D1 and D2 receptors is not valid for accumbens projections.

Kupchik YM, Brown RM, Heinsbroek JA, Lobo MK, Schwartz DJ, Kalivas PW.

Nat Neurosci. 2015 Sep;18(9):1230-2. doi: 10.1038/nn.4068. Epub 2015 Jul 27.

15.

Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis.

Hannan TJ, Roberts PL, Riehl TE, van der Post S, Binkley JM, Schwartz DJ, Miyoshi H, Mack M, Schwendener RA, Hooton TM, Stappenbeck TS, Hansson GC, Stenson WF, Colonna M, Stapleton AE, Hultgren SJ.

EBioMedicine. 2014 Oct 24;1(1):46-57. doi: 10.1016/j.ebiom.2014.10.011. eCollection 2014 Nov.

16.

Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity.

Goneau LW, Hannan TJ, MacPhee RA, Schwartz DJ, Macklaim JM, Gloor GB, Razvi H, Reid G, Hultgren SJ, Burton JP.

MBio. 2015 Mar 31;6(2). pii: e00356-15. doi: 10.1128/mBio.00356-15.

17.

Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection.

Schwartz DJ, Conover MS, Hannan TJ, Hultgren SJ.

PLoS Pathog. 2015 Jan 8;11(1):e1004599. doi: 10.1371/journal.ppat.1004599. eCollection 2015 Jan.

18.

Impact of host age and parity on susceptibility to severe urinary tract infection in a murine model.

Kline KA, Schwartz DJ, Gilbert NM, Lewis AL.

PLoS One. 2014 May 16;9(5):e97798. doi: 10.1371/journal.pone.0097798. eCollection 2014.

19.

Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation.

Schwartz DJ, Kalas V, Pinkner JS, Chen SL, Spaulding CN, Dodson KW, Hultgren SJ.

Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15530-7. doi: 10.1073/pnas.1315203110. Epub 2013 Sep 3.

20.

Prospective evaluation of the nature, course, and impact of acute sleep abnormality after traumatic brain injury.

Nakase-Richardson R, Sherer M, Barnett SD, Yablon SA, Evans CC, Kretzmer T, Schwartz DJ, Modarres M.

Arch Phys Med Rehabil. 2013 May;94(5):875-82. doi: 10.1016/j.apmr.2013.01.001. Epub 2013 Jan 4.

PMID:
23296143
21.

Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli.

Kline KA, Schwartz DJ, Gilbert NM, Hultgren SJ, Lewis AL.

Infect Immun. 2012 Dec;80(12):4186-94. doi: 10.1128/IAI.00684-12. Epub 2012 Sep 17.

22.

The effects of arterial blood pressure on rebleeding when BleedArrest, Celox and TraumaDex are used in a porcine model of lethal femoral injury.

Burgert J, Gegel B, Neal AR, Kammer KE, Paul ME, Schwartz DJ, Loughren M, Johnson A.

Mil Med. 2012 Mar;177(3):340-4.

PMID:
22479924
23.

Lower GI bleeding from ileocolonic histoplasmosis.

Patel NM, Schwartz DJ.

Gastrointest Endosc. 2011 Dec;74(6):1404-5; discussion 1405-6. doi: 10.1016/j.gie.2011.07.058. Epub 2011 Oct 1. No abstract available.

PMID:
21963061
24.

Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.

Schwartz DJ, Chen SL, Hultgren SJ, Seed PC.

Infect Immun. 2011 Oct;79(10):4250-9. doi: 10.1128/IAI.05339-11. Epub 2011 Aug 1.

25.

Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection.

Kline KA, Schwartz DJ, Lewis WG, Hultgren SJ, Lewis AL.

Infect Immun. 2011 Sep;79(9):3588-95. doi: 10.1128/IAI.00122-11. Epub 2011 Jun 20.

26.

Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).

Neben-Wittich MA, Atherton PJ, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, Loprinzi CL, Burger KN, Martenson JA, Miller RC.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):397-402. doi: 10.1016/j.ijrobp.2010.05.065. Epub 2010 Oct 1.

27.

Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.

Miller RC, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, Stoffel TJ, Haselow RE, Schaefer PL, Bearden JD 3rd, Atherton PJ, Loprinzi CL, Martenson JA.

Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1460-6. doi: 10.1016/j.ijrobp.2010.01.031. Epub 2010 Aug 26.

28.

Evidence for early right ventricular and septal mechanical activation (interventricular dyssynchrony) in pulmonary hypertension.

Schwartz DJ, Kop WJ, Park MH, Vesely MR, Li S, Mehra MR, Gottdiener JS.

Am J Cardiol. 2008 Nov 1;102(9):1273-7. doi: 10.1016/j.amjcard.2008.06.062. Epub 2008 Aug 29.

PMID:
18940306
30.

Prediction of radial distance of extraprostatic extension from pretherapy factors.

Schwartz DJ, Sengupta S, Hillman DW, Sargent DJ, Cheville JC, Wilson TM, Mynderse LA, Choo R, Davis BJ.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):411-8.

PMID:
17869661
31.

On a characteristic of cortical arousals in individuals with obstructive sleep apnea.

Schwartz DJ, Moxley P, Barker A, Longman M.

J Clin Sleep Med. 2005 Jan 15;1(1):35-40.

PMID:
17561613
32.
33.

Coordination copolymerization of severely encumbered isoalkenes with ethylene: enhanced enchainment mediated by binuclear catalysts and cocatalysts.

Li H, Li L, Schwartz DJ, Metz MV, Marks TJ, Liable-Sands L, Rheingold AL.

J Am Chem Soc. 2005 Oct 26;127(42):14756-68.

PMID:
16231930
34.
35.

Aspirin in the prevention of cardiovascular disease in women.

Schwartz DJ.

N Engl J Med. 2005 Jun 30;352(26):2751-2; author reply 2751-2. No abstract available.

PMID:
15987927
36.
37.

Depressive symptoms are independently predictive of carotid atherosclerosis.

Haas DC, Davidson KW, Schwartz DJ, Rieckmann N, Roman MJ, Pickering TG, Gerin W, Schwartz JE.

Am J Cardiol. 2005 Feb 15;95(4):547-50.

PMID:
15695154
38.

Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy.

Schwartz DJ, Schild SE, Wong WW, Vora SA.

Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):60-3.

PMID:
15629594
39.

Selective identification of different brachytherapy sources, ferromagnetic seeds, and fiducials in the prostate using an automated seed sorting algorithm.

Davis BJ, Brinkmann DH, Kruse JJ, Herman MG, LaJoie WN, Schwartz DJ, Pisansky TM, Kline RW.

Brachytherapy. 2004;3(2):106-12.

PMID:
15374543
40.

Building a cardiology practice.

Greenberg DI, Blonder RD, Eastburn TE, Smith GS, Schwartz DJ, Miller JB, Glass JM, Lee JR, Ascarelli ED, Rosenbaum DA, Harris NG, Mantia W, Keledjian LM.

J Cardiovasc Manag. 2004 Mar-Apr;15(2):16-8.

PMID:
15185626
41.

Radiation exposure to operating room personnel during transperineal interstitial permanent prostate brachytherapy.

Schwartz DJ, Davis BJ, Vetter RJ, Pisansky TM, Herman MG, Wilson TM, LaJoie WN, Oberg AL.

Brachytherapy. 2003;2(2):98-102.

PMID:
15062147
43.

Body image, psychological functioning, and parental feedback regarding physical appearance.

Schwartz DJ, Phares V, Tantleff-Dunn S, Thompson JK.

Int J Eat Disord. 1999 Apr;25(3):339-43.

PMID:
10192000
44.

Is license exam a failure?

Schwartz DJ.

J Am Dent Assoc. 1995 Feb;126(2):146. No abstract available.

PMID:
7860882
45.

The relationship between 1-year mortality and infarct location in patients with non-Q wave myocardial infarction.

Schechtman KB, Kleiger RE, Boden WE, Capone RJ, Schwartz DJ, Roberts R, Gibson RS.

Am Heart J. 1992 May;123(5):1175-81.

PMID:
1575129
46.

Pharmacokinetic and pharmacodynamic comparison of an osmotic release oral metoprolol tablet and the metoprolol conventional tablet.

Feliciano NR, Bouvet AA, Redalieu E, Castellana J, Luders RC, Schwartz DJ, Shum L, Zak S, Arnold JD, Leese PT.

Am Heart J. 1990 Aug;120(2):483-9.

PMID:
2382633
47.
48.

Frequency and significance of late evolution of Q waves in patients with initial non-Q-wave acute myocardial infarction. Diltiazem Reinfarction Study Group.

Kleiger RE, Boden WE, Schechtman KB, Gibson RS, Schwartz DJ, Geiger BJ, Capone RJ, Roberts R.

Am J Cardiol. 1990 Jan 1;65(1):23-7.

PMID:
2403730
49.

Risk stratification of patients with non-Q wave myocardial infarction. The critical role of ST segment depression. The Diltiazem Reinfarction Study Research Group.

Schechtman KB, Capone RJ, Kleiger RE, Gibson RS, Schwartz DJ, Roberts R, Young PM, Boden WE.

Circulation. 1989 Nov;80(5):1148-58.

PMID:
2805257
50.

Importance of early recurrent ischemia on one-year survival after non-Q-wave acute myocardial infarction. Diltiazem Reinfarction Study Research Group.

Boden WE, Gibson RS, Kleiger RE, Schechtman KB, Capone RJ, Schwartz DJ, Roberts R.

Am J Cardiol. 1989 Oct 1;64(12):799-801. No abstract available.

PMID:
2801533

Supplemental Content

Loading ...
Support Center